Pardi D S, Tremaine W J, Sandborn W J, McCarthy J T
Inflammatory Bowel Disease Clinic, Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, Minnesota, USA.
Am J Gastroenterol. 1998 Apr;93(4):504-14. doi: 10.1111/j.1572-0241.1998.156_b.x.
Renal and urologic complications are not uncommon in patients with inflammatory bowel disease, and can be directly or indirectly related to the underlying disease process or its treatment. Many of these patients have asymptomatic disease, or the urinary symptoms are nonspecific or overshadowed by bowel symptoms. By the time a urinary complication is considered, significant disease progression or renal damage may have occurred. These risks necessitate a high degree of diligence and periodic urologic evaluation as part of the long-term management of patients with inflammatory bowel disease.
肾脏和泌尿系统并发症在炎症性肠病患者中并不少见,并且可能与潜在的疾病进程或其治疗直接或间接相关。这些患者中的许多人患有无症状疾病,或者泌尿系统症状不具有特异性,或者被肠道症状所掩盖。当考虑到泌尿系统并发症时,可能已经发生了显著的疾病进展或肾脏损害。这些风险使得在炎症性肠病患者的长期管理中,需要高度的勤勉和定期的泌尿系统评估。